ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VRP Verona Pharma Plc

55.00
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Verona Pharma Plc LSE:VRP London Ordinary Share GB00BYW2KH80 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 55.00 45.00 65.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Verona Pharma PLC PDMR Dealing (3484Y)

02/03/2017 9:36am

UK Regulatory


Verona Pharma (LSE:VRP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Verona Pharma Charts.

TIDMVRP

RNS Number : 3484Y

Verona Pharma PLC

02 March 2017

Verona Pharma plc

PDMR Dealing

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Dr. Jan-Anders Karlsson 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                Chief Executive Officer 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Verona Pharma plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      n/a 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of         Ordinary Shares of 5 pence each 
       instrument                                                GB00BYW2KH80 
       Identification code 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Jan-Anders Karlsson purchased 19,750 Ordinary Shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                      Price(s)        Volume(s) 
                                                                 --------------  --------------- 
                                                                  149 pence       12,000 
                                                                   per Ordinary    Ordinary 
                                                                   Share           Shares 
                                                                 --------------  --------------- 
                                                                  149 pence       7,750 Ordinary 
                                                                   per Ordinary    Shares 
                                                                   Share 
                                                                 --------------  --------------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                   19,750 Ordinary Shares at 149 pence per Ordinary Share 
        - Aggregated volume 
        - Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
 e)    Date of the transaction                                  12,000 Ordinary Shares on 28 February 2017 and 7,750 
                                                                Ordinary Shares on 1 March 2017 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 London Stock Exchange, AIM 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANDAEDFXEEF

(END) Dow Jones Newswires

March 02, 2017 04:36 ET (09:36 GMT)

1 Year Verona Pharma Chart

1 Year Verona Pharma Chart

1 Month Verona Pharma Chart

1 Month Verona Pharma Chart

Your Recent History

Delayed Upgrade Clock